IntegraGen SA (EPA:ALINT)
France · Delayed Price · Currency is EUR 0.1995
-0.0195 (-8.90%)
Sep 11, 2026, 3:07 PM CET
IntegraGen Market Cap
IntegraGen has a market cap or net worth of €1.32 million as of September 11, 2026. Its market cap has decreased by -28.00% in one year.
Market Cap
1.32M
Enterprise Value
505.02K
Revenue
5.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.20
ChartMarket Cap Chart
Since June 18, 2010, IntegraGen's market cap has decreased from 34.24M to 1.32M, a decrease of -96.16%. That is a compound annual growth rate of -18.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.32M | 49.41% |
| Dec 31, 2025 | 880.55K | -76.46% |
| Dec 31, 2024 | 3.74M | -36.97% |
| Dec 29, 2023 | 5.93M | -25.72% |
| Dec 30, 2022 | 7.99M | 8.73% |
| Dec 31, 2021 | 7.35M | -46.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 22.77M |
| Aelis Farma | 13.76M |
| Advicenne | 13.09M |
| Aton | 11.92M |
| NFL Biosciences | 11.21M |
| TME Pharma | 11.20M |
| Poxel | 10.06M |
| Biophytis | 6.20M |